Trial intelligence / Profile preview

Pirfenidone for prevention of urethral stricture recurrence after cold-knife internal urethrotomy

ChiCTR1900021654Phase 4Recruiting

Sponsor
Shanghai Sixth People's Hospital
Start
Mar 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of pirfenidone in Urethral stenosis (2 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoints: Urinary flow rate and Urethrography. Started Mar 2019; status: recruiting.

02

Drugs

pirfenidone
03

Conditions

Urethral stenosis

Beyond the preview

Go deeper on ChiCTR1900021654.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900021654.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call